Clinical features and survival of treatment with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease.

被引：0
|
作者：
Mendoza, M. A. P. [1 ]
Contreras, A. [1 ]
Lafuente, G. [1 ]
Luque Buzo, E. [1 ]
De la Casa Fages, B. [1 ]
Gonzalez, M. [1 ]
Perez Sanchez, J. [2 ]
Grandas Perez, F. [1 ]
机构：
[1] Dept Neurol, Madrid, Spain
[2] Movement Disorders Unit, Madrid, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-636
引用
收藏
页码：836 / 836
页数：1
相关论文
共 50 条
  • [31] Efficacy of levodopa-carbidopa intestinal GEL infusion on advanced Parkinson's disease patients at our hospital
    Sakata, M.
    Hiwatani, Y.
    Matsumoto, T.
    Minamino, M.
    Hironishi, M.
    Ito, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 728 - 728
  • [32] Safety of Levodopa-carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease Patients Receiving=2000 mg Daily Dose of Levodopa
    Zadikoff, Cindy
    Boyd, James T.
    Dubow, Stephanie
    Bergmann, Lars
    Robieson, Weining Z.
    Ijacu, Horia
    Benesh, Janet
    MOVEMENT DISORDERS, 2018, 33 : S90 - S91
  • [33] A Long-term Study on Effectiveness of Levodopa-carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease Patients
    Chaudhuri, K. Ray
    Antonini, Angelo
    Poewe, Werner
    Standaert, David
    Odin, Per
    Zamudio, Jorge
    Bergmann, Lars
    NEUROLOGY, 2018, 90
  • [34] Continuous intrajejunal levodopa-carbidopa intestinal gel in the treatment of patients with advanced Parkinson's disease - effects on motor symptoms
    Gmitterova, Karin
    Minar, Michal
    Smutny, Milan
    Valkovic, Peter
    ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2015, 57 (03): : 57 - 62
  • [35] A long-term study on effectiveness of levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease patients
    Chaudhuri, K. R.
    Antonini, A.
    Poewe, W.
    Standaert, D.
    Odin, P.
    Zamudio, J.
    Bergmann, L.
    MOVEMENT DISORDERS, 2017, 32
  • [36] A long-term Study on Effectiveness of Levodopa-carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease Patients
    Chaudhuri, K. Ray
    Antonini, Angelo
    Poewe, Werner
    Standaert, David
    Odin, Per
    Zamudio, Jorge
    Bergmann, Lars
    MOVEMENT DISORDERS, 2018, 33 : S90 - S90
  • [37] Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease Patients Receiving ≥ 2000 mg Daily Dose of Levodopa
    Zadikoff, Cindy
    Boyd, James
    Dubow, Stephanie
    Bergmann, Lars
    Robieson, Weining
    Ijacu, Horia
    Benesh, Janet
    NEUROLOGY, 2018, 90
  • [38] Stable levodopa plasma levels with jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Nyholm, D.
    Odin, P.
    Johansson, A.
    Chatamra, K.
    Locke, C.
    Freeman, S.
    Dutta, S.
    Othman, A. A.
    MOVEMENT DISORDERS, 2012, 27 : S131 - S131
  • [39] Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
    Antonini, Angelo
    Poewe, Werner
    Chaudhuri, K. Ray
    Jech, Robert
    Pickut, Barbara
    Pirtosek, Zvezdan
    Szasz, Jozsef
    Valldeoriola, Francesc
    Winkler, Christian
    Bergmann, Lars
    Yegin, Ashley
    Onuk, Koray
    Barch, David
    Odin, Per
    PARKINSONISM & RELATED DISORDERS, 2017, 45 : 13 - 20
  • [40] Long-Term Safety and Efficacy of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Fernandez, Hubert H.
    Boyd, James T.
    Fung, Victor S. C.
    Lew, Mark F.
    Rodriguez, Ramon L.
    Slevin, John T.
    Standaert, David G.
    Zadikoff, Cindy
    Vanagunas, Arvydas D.
    Chatamra, Krai
    Eaton, Susan
    Facheris, Maurizio F.
    Hall, Coleen
    Robieson, Weining Z.
    Benesh, Janet
    Espay, Alberto J.
    MOVEMENT DISORDERS, 2018, 33 (06) : 928 - 936
12345